90 related articles for article (PubMed ID: 17235610)
1. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
[TBL] [Abstract][Full Text] [Related]
2. Selective Serotonin Reuptake Inhibitors within Cells: Temporal Resolution in Cytoplasm, Endoplasmic Reticulum, and Membrane.
Nichols AL; Blumenfeld Z; Luebbert L; Knox HJ; Muthusamy AK; Marvin JS; Kim CH; Grant SN; Walton DP; Cohen BN; Hammar R; Looger L; Artursson P; Dougherty DA; Lester HA
J Neurosci; 2023 Mar; 43(13):2222-2241. PubMed ID: 36868853
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter occupancy and the functional neuroanatomic effects of citalopram in geriatric depression.
Smith GS; Kahn A; Sacher J; Rusjan P; van Eimeren T; Flint A; Wilson AA
Am J Geriatr Psychiatry; 2011 Dec; 19(12):1016-25. PubMed ID: 21841458
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of SERT Expression and Antidepressant-like Response to Escitalopram in Wild-Type and SERT Mutant Mice.
Mitchell NC; Gould GG; Koek W; Daws LC
J Pharmacol Exp Ther; 2016 Aug; 358(2):271-81. PubMed ID: 27288483
[TBL] [Abstract][Full Text] [Related]
5. Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder.
Wu CH; Chang CS; Yang YK; Shen LH; Yao WJ
PLoS One; 2017; 12(2):e0170886. PubMed ID: 28182708
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylation Regulates Human Serotonin Transporter Activity, Trafficking, and Expression and Is Modulated by Escitalopram.
Brown CR; Foster JD
ACS Chem Neurosci; 2023 Sep; 14(18):3431-3443. PubMed ID: 37644775
[TBL] [Abstract][Full Text] [Related]
7. Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport.
Roweth HG; Yan R; Bedwani NH; Chauhan A; Fowler N; Watson AH; Malcor JD; Sage SO; Jarvis GE
Sci Rep; 2018 Feb; 8(1):3494. PubMed ID: 29472624
[TBL] [Abstract][Full Text] [Related]
8. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.
Hjorth OR; Frick A; Gingnell M; Hoppe JM; Faria V; Hultberg S; Alaie I; Månsson KNT; Rosén J; Reis M; Wahlstedt K; Jonasson M; Lubberink M; Antoni G; Fredrikson M; Furmark T
Transl Psychiatry; 2021 Nov; 11(1):559. PubMed ID: 34732695
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid P component (SAP) modulates antidepressant effects through promoting membrane insertion of the serotonin transporter.
Su P; Yan S; Yang J; Tong J; Samsom J; You F; Li Y; Chen Q; Jiang A; Zhai D; Chen J; Sun Z; Zhou J; Liu M; Lee FJS; Xu ZD; Wang X; Vasdev N; Wong AHC; Liu F
Neuropsychopharmacology; 2023 Feb; 48(3):508-517. PubMed ID: 36076020
[TBL] [Abstract][Full Text] [Related]
10. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study.
Boucherie DE; Reneman L; Booij J; Martins D; Dipasquale O; Schrantee A
J Psychopharmacol; 2023 Dec; 37(12):1209-1217. PubMed ID: 37947344
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter imaging agent as a probe for β-cells of pancreas.
Sun Y; Li G; Hong H; Zhu L; Kung HF; Zhang Y; Zhu J
Nucl Med Biol; 2024; 130-131():108894. PubMed ID: 38422917
[TBL] [Abstract][Full Text] [Related]
12. Escitalopram attenuates posterior cingulate activity during self-evaluation in healthy volunteers.
Matthews SC; Simmons AN; Strigo IA; Arce E; Stein MB; Paulus MP
Psychiatry Res; 2010 May; 182(2):81-7. PubMed ID: 20418072
[TBL] [Abstract][Full Text] [Related]
13. The effect of a single dose of escitalopram on sensorimotor networks.
Weisstanner C; Kägi G; Krammer W; Eap CB; Wiest R; Missimer JH; Weder BJ
Brain Behav; 2018 Jun; 8(6):e00975. PubMed ID: 30106253
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylation regulates human serotonin transporter activity, trafficking, and expression and is modulated by escitalopram.
Brown CR; Foster JD
bioRxiv; 2023 May; ():. PubMed ID: 37214849
[TBL] [Abstract][Full Text] [Related]
15. Micelle enhanced fluorimetric and thin layer chromatography densitometric methods for the determination of (+/-) citalopram and its S-enantiomer escitalopram.
Taha EA; Salama NN; Wang S
Anal Chem Insights; 2009 Apr; 4():1-9. PubMed ID: 19652757
[TBL] [Abstract][Full Text] [Related]
16. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
[TBL] [Abstract][Full Text] [Related]
17. Regional Differences in Serotonin Transporter Occupancy by Escitalopram: An [
Kim E; Howes OD; Kim BH; Chon MW; Seo S; Turkheimer FE; Lee JS; Lee YS; Kwon JS
Clin Pharmacokinet; 2017 Apr; 56(4):371-381. PubMed ID: 27557550
[TBL] [Abstract][Full Text] [Related]
18. The clinical pharmacokinetics of escitalopram.
Rao N
Clin Pharmacokinet; 2007; 46(4):281-90. PubMed ID: 17375980
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy.
Eichentopf L; Hiemke C; Conca A; Engelmann J; Gerlach M; Havemann-Reinecke U; Hefner G; Florio V; Kuzin M; Lieb K; Reis M; Riemer TG; Serretti A; Schoretsanitis G; Zernig G; Gründer G; Hart XM
Front Psychiatry; 2022; 13():972141. PubMed ID: 36325531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
